S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Sourcebio International (SBI) Share Forecast, Price & News

GBX 125
0.00 (0.00%)
(As of 05/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
23,356 shs
Average Volume
64,390 shs
Market Capitalization
£92.73 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SBI News and Ratings via Email

Sign-up to receive the latest news and ratings for Sourcebio International and its competitors with MarketBeat's FREE daily newsletter.

Sourcebio International logo

About Sourcebio International

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, and the United States. The company's services cover histopathology reporting and human tissue testing services; genomics services to pharmaceuticals, biotechnology, life science, and academic markets; stability storage solutions; and COVID-19 antigen PCR testing services. It also manufactures reagents and kits for the blood group serology, blood banking, and tissue banking sectors; and engages in life science research activities, which cover antibodies, clones, cell culture reagents and assays, protein biology, laboratory essentials, and others. Sourcebio International Plc was incorporated in 2016 and is headquartered in Nottingham, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Medical Care Facilities
Year Founded

Sales & Book Value

Annual Sales
£92.40 million
Cash Flow
GBX 44.02 per share
Book Value
GBX 65.10 per share


Pretax Margin




Free Float
Market Cap
£92.73 million
Not Optionable


Overall MarketRank

2.28 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Sourcebio International (LON:SBI) Frequently Asked Questions

Is Sourcebio International a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sourcebio International in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sourcebio International stock.
View analyst ratings for Sourcebio International
or view top-rated stocks.

What price target have analysts set for SBI?

1 analysts have issued 1-year price targets for Sourcebio International's stock. Their forecasts range from GBX 220 to GBX 220. On average, they anticipate Sourcebio International's stock price to reach GBX 220 in the next twelve months. This suggests a possible upside of 76.0% from the stock's current price.
View analysts' price targets for Sourcebio International
or view top-rated stocks among Wall Street analysts.

Who are Sourcebio International's key executives?
Sourcebio International's management team includes the following people:
  • Mr. Jay Charles LeCoque, Exec. Chairman (Age 59)
  • Mr. Anthony James Ratcliffe, CFO, Company Sec. & Exec. Director (Age 58)
  • Mr. Russell Wheatcroft, Chief Operating Officer
What is Sourcebio International's stock symbol?

Sourcebio International trades on the London Stock Exchange (LON) under the ticker symbol "SBI."

How do I buy shares of Sourcebio International?

Shares of SBI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sourcebio International's stock price today?

One share of SBI stock can currently be purchased for approximately GBX 125.

How much money does Sourcebio International make?

Sourcebio International has a market capitalization of £92.73 million and generates £92.40 million in revenue each year.

How many employees does Sourcebio International have?

Sourcebio International employs 194 workers across the globe.

What is Sourcebio International's official website?

The official website for Sourcebio International is www.sourcebioscience.com.

How can I contact Sourcebio International?

Sourcebio International's mailing address is 620 Eighth Avenue, New York, New York 10018. The company can be reached via phone at 44 11 5973 9012.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.